C12Q 2521/301
Endonuclease
C12Q2521/301 (Endonuclease) appears on 84 US grants and 158 published applications in this corpus.
Search patents in C12Q- Granted patents
- 84
- Published applications
- 158
- Assignees
- 94
- Inventors
- 321
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 3 |
| 2012 | 0 | 1 |
| 2013 | 1 | 2 |
| 2014 | 0 | 3 |
| 2015 | 2 | 4 |
| 2016 | 5 | 6 |
| 2017 | 5 | 6 |
| 2018 | 3 | 11 |
| 2019 | 3 | 18 |
| 2020 | 10 | 26 |
| 2021 | 7 | 18 |
| 2022 | 4 | 13 |
| 2023 | 14 | 10 |
| 2024 | 10 | 14 |
| 2025 | 8 | 14 |
| 2026 | 8 | 8 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods for genome assembly and haplotype phasing1 Sep 2026US 12,725,678 B2The Regents of the University of California
- Chromosome conformation markers of autism spectrum disorder28 Jul 2026US 12,692,543 B2Oxford Biodynamics PLC
- Method for detection of specific nucleic acids14 Jul 2026US 12,680,124 B2Siemens Healthineers AG
- Methods for manipulating biomolecules30 Jun 2026US 12,668,825 B2Life Technologies Corporation
- RNA-directed DNA cleavage by the Cas9-crRNA complex23 Jun 2026US 12,662,668 B2Vilnius University
- Rna-guided nucleases and active fragments and variants thereof and methods of use3 Sep 2026US 2026/0258452 A1Life Edit Therapeutics, Inc.
- Application of epigenetic chromsomal interactions in cancer diagnostics27 Aug 2026US 2026/0250783 A1Oxford Biodynamics PLC
- Transposition into native chromatin for personal epigenomics11 Jun 2026US 2026/0159884 A1The Board of Trustees of the Leland Stanford Junior University
- Detecting ovarian cancer19 Mar 2026US 2026/0078450 A1Exact Sciences Corporation
- T cell-targeted t cells19 Feb 2026US 2026/0049139 A1UCL Business PLC
Most cited
By later US patents
- Transposition of native chromatin for personal epigenomics255US 10,059,989 B2The Board of Trustees of the Leland Stanford Junior University · 2018
- Transposition of native chromatin for personal epigenomics82US 10,150,995 B1The Board of Trustees of the Leland Stanford Junior University · 2018
- Enzymatic inverse polymerase chain reaction56US 5,514,568 AEli Lilly and Company · 1996
- Method for attaching a counter sequence to a nucleic acid sample55US 9,670,529 B2Population Genetics Technologies Ltd · 2017
- Systems and methods for analyzing sequence data49US 9,817,944 B2Seven Bridges Genomics Inc. · 2017